XT
XTX Topco’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,623
| Closed | -$282K | – | 2483 |
|
|
2025
Q1 | $282K | Sell |
11,623
-15,179
| -57% | -$368K | 0.01% | 1457 |
|
|
2024
Q4 | $559K | Buy |
26,802
+7,508
| +39% | +$157K | 0.05% | 670 |
|
|
2024
Q3 | $384K | Buy |
19,294
+8,160
| +73% | +$162K | 0.03% | 1017 |
|
|
2024
Q2 | $172K | Buy |
11,134
+773
| +7% | +$12K | 0.01% | 1294 |
|
|
2024
Q1 | $165K | Buy |
+10,361
| New | +$165K | 0.02% | 1233 |
|
|
2023
Q4 | – | Sell |
-13,227
| Closed | -$155K | – | 1677 |
|
|
2023
Q3 | $155K | Buy |
+13,227
| New | +$155K | 0.03% | 1097 |
|
|
2022
Q4 | – | Sell |
-22,534
| Closed | -$289K | – | 1183 |
|
|
2022
Q3 | $289K | Buy |
+22,534
| New | +$289K | 0.07% | 529 |
|
|
2022
Q1 | – | Sell |
-19,253
| Closed | -$130K | – | 712 |
|
|
2021
Q4 | $130K | Buy |
19,253
+6,925
| +56% | +$46.8K | 0.07% | 427 |
|
|
2021
Q3 | $65K | Sell |
12,328
-6,888
| -36% | -$36.3K | 0.02% | 587 |
|
|
2021
Q2 | $110K | Buy |
+19,216
| New | +$110K | 0.04% | 648 |
|